Thank you, Steve. Earlier this morning we announced our third quarter earnings. Our net investment income increased by approximately 4.8% to $0.27 per share. Our net asset value per share decreased modestly by 1.9% to $11.29 per share. With respect to net investment income, while we had an improvement this quarter, we remain focused on increasing this metric longer term primarily by rotating certain non-interest earning equity positions into interest earning assets. As we discussed on our last call, we continue to explore potential alternatives for our minority equity investment in Pfanstiehl, our largest equity position. In the meantime, the fair value of the position continued to improve this quarter, appreciating by $2.8 million to $73.7 million at quarter end. The increase in value is primarily attributed to improved fundamental performance of the company. As a reminder, this is a position we invested in more than 10 years ago at a cost of only $200,000. To date, we have received $3.4 million in distributions for approximately 16 times our cost. Our net asset value per share decreased by 1.9% as a result of certain markdowns during the quarter in our loan and structured finance positions, which were offset by an increase in the value of our equity positions notably Pfanstiehl. Our nonaccrual metrics as a percentage of our total portfolio at fair value were relatively stable compared to the prior quarter. We removed one loan, which had previously been on nonaccrual status during the quarter and we placed one loan on nonaccrual this quarter representing only 0.6% of the total portfolio at fair value. Overall, we believe the portfolio continues to be well positioned for the current macroeconomic environment. As part of our longstanding investment discipline, we remain committed to avoiding highly cyclical industries. We believe that our loan portfolio remains well diversified and defensively positioned. At quarter end, our largest sector exposures at fair value are in manufacturing and healthcare. Another key part of our investment discipline is investing higher in the capital structure with 100% of our loan portfolio at fair value in first-lien and second-lien senior secured loans. In our view, our financing continues to benefit our company. At the end of the third quarter 100% of our outstanding debt matures in 2026 or later and 72% of our outstanding debt is unsecured. Our non-recourse $150 million floating rate facility with BNP Paribas matures in June 2027. Our Bank of California floating rate corporate line of credit provides us additional liquidity and flexibility. As we have discussed before, in 2021 we locked in $180 million of fixed rate, unsecured debt bearing a weighted average coupon of 4.8% which remains notably lower than current market pricing. Looking ahead, we believe the recent interest rate cut by the Federal Reserve and potential additional interest rate reductions in the near-to-medium term will put some pressure on our net interest margin. However, we also believe that lower interest rates should have a positive impact on the health of the loan portfolio as it decreases the debt service burden on our borrowers. Additionally, we believe that lower rates reduce the risk of a recession which would bode well for our portfolio. We expect M&A activity to pick-up in the coming quarters, which could lead to higher originations and fee income and a potential positive impact on net investment income. As we navigate this market environment, we have confidence in the experience of our advisor which manages approximately $3.9 billion across the loan and structured credit markets, has expertise in multiple asset classes and industries, and has a more than 25-year track record through multiple credit cycles. At this point, I'll turn the call over to Jeff Cerny, our Chief Financial Officer to give you more details and color for the quarter.